Silver Book Fact

TAVR v. SAVR in Intermediate-Risk SAS Patients

At 1-year, severe aortic stenosis (SAS) patients with intermediate surgical mortality risk who underwent transcatheter aortic valve replacement (TAVR), had all-cause mortality rates of 7.4% (compared to 13% for surgical aortic valve replacement (SAVR)), disabling stroke rates of 2.3% (compared to 5.9% for SAVR), and rehospitalization rates of 11.4% (compared to 15.1% for SAVR).

Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Intermediate-Risk Patients: A propensity score analysis. Lancet. 2016; 387(10034): 2218-25. http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)30073-3/references

Reference

Title
Transcatheter Aortic Valve Replacement Versus Surgical Valve Replacement in Intermediate-Risk Patients: A propensity score analysis
Publication
Lancet
Publication Date
2016
Volume & Issue
Volume 387, Issue 10034
Pages
2218-25
URL
Read Full Resource

Categories

  • Innovative Medical Research
  • Human Value

Related Facts

  • Surgical Aortic Valve Replacements in 2010
    In 2010, ~67,500 surgical aortic valve replacements (SAVR) were performed in the U.S.  
  • In 2010, ~67,500 SAVRs were performed in the U.S.
     
  • Survival rates of SAS patients ages 80+ with and without SAVR
     
  • Cost-effectiveness of SAVR
    The cost-effectiveness ratio for surgical aortic valve replacement (SAVR), compared to no surgery, was estimated at $13,528 per quality-adjusted life year (QALY) (~$17,225 in 2017 dollars).  
  • TAVR improves quality of life in SAS patients